Security key
114082407
- Security type / class
- Equity / COM
- Total 13F shares
- 35,525
- Total 13F value
- $236,242
- Share change
- +35,524
- SEC-reported price per share
- $6.65
- Number of holders
- 9
- Value change
- +$236,235
- Number of buys
- 8
Report period
Q2 2026
Institutions
9
Top holders
9
ERNA full security history
Ownership snapshot
Full 13F holder table
Ernexa Therapeutics Inc. SEC filings
Ernexa Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 114082407
Recent filing periods:
Ownership snapshot
Top reported holders of ERNA - Ernexa Therapeutics Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Charles Cherington
Disclosed value leader
Charles Cherington
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 35%
13D/G row: Charles Cherington
Showing 1-6 of 15 holder rows.
Quick read
Charles Cherington leads the comparable SEC ownership view at 35%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Charles Cherington's linked filing trail.
Comparable ownership
Top 5
Charles Cherington
35%
Freebird Partners LP
9.9%
Shameek Konar
9.7%
Bleichroeder LP
6.9%
John D. Halpern
5.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Charles Cherington |
13D/G
3/4/5
10%+ Owner
|
35%
|
$12,949,602
10,791,335 shares
|
$0 | 10 Feb 2026 |
| Freebird Partners LP |
3/4/5
13D/G
10%+ Owner
|
9.9%
from 13D/G
|
$1,503,337
2,774,627 shares
mixed-class rows
|
— | 14 Dec 2023 |
| Shameek Konar |
13D/G
|
9.7%
|
$21,302
118,342 shares
|
-$597,053 | 10 Feb 2026 |
| Bleichroeder LP |
13F
13D/G
Company
|
6.9%
from 13D/G
|
$454,000
4,000,000 shares
mixed-class rows
|
— | 31 Mar 2026 |
| John D. Halpern |
3/4/5
13D/G
10%+ Owner
|
5.6%
from 13D/G
|
$1,118,891
1,123,006 shares
mixed-class rows
|
— | 02 Dec 2022 |
| Nicholas J. Singer |
3/4/5
13D/G
Director · Nicholas Jason Singer
|
4.9%
from 13D/G
|
$962,330
954,608 shares
mixed-class rows
|
— | 02 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
35,525
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
0
Q2 2026 holders
9
Holder diff
9
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend